2019-09-13
2019-09-13
Plenary Hall
Ballroom A
Ballroom B
Exhibit and Poster Hall
2019-09-14
2019-09-14
Plenary Hall
Ballroom A
Ballroom B
Exhibit and Poster Hall
2019-09-15
2019-09-15
Plenary Hall
Ballroom A
Ballroom B
Plenary Hall
Ballroom A
Ballroom B
Exhibit and Poster Hall
Plenary Hall
Ballroom A
Ballroom B
Exhibit and Poster Hall
Plenary Hall
Ballroom A
Ballroom B
07:00 - 19:00
Registration
07:30 - 08:30
Morning Session 1: MSC therapy; Rationalism vs. Empiricism; How much must we know to test therapies in patients; a Live Debate
Morning Session 1: MSC therapy; Rationalism vs. Empiricism; How much must we know to test therapies in patients; a Live Debate image
Allan B. Dietz, PhD (Chair)
Mayo Clinic, USA
Morning Session 1: MSC therapy; Rationalism vs. Empiricism; How much must we know to test therapies in patients; a Live Debate image
Jacques Galipeau, MD
University of Wisconsin - Madison, USA
Morning Session 1: MSC therapy; Rationalism vs. Empiricism; How much must we know to test therapies in patients; a Live Debate image
William Faubion, MD
Mayo Clinic, USA
07:30 - 08:30
Q&O Track 1: Media Fills
08:45 - 10:15
Plenary 1: Mesenchymal and Progenitor Stem Cells: Results from the Clinic and the Future of Living Drugs
Plenary 1: Mesenchymal and Progenitor Stem Cells: Results from the Clinic and the Future of Living Drugs image
Allan B. Dietz, PhD (Chair)
Mayo Clinic, USA
Donna Skerrett, MD, MS
Mesoblast, USA
Plenary 1: Mesenchymal and Progenitor Stem Cells: Results from the Clinic and the Future of Living Drugs image
Gil Van Bokkelen, PhD
Athersys, USA
Plenary 1: Mesenchymal and Progenitor Stem Cells: Results from the Clinic and the Future of Living Drugs image
Etienne Sokal, MD, PhD
Promethera, Belgium
10:15 - 10:45
Coffee Break
10:45 - 12:15
Oral Abstracts Session 1
10:45 - 12:15
Workshop 1: ISCT-NAVRMA Joint Session – Veterinary Medicine in Developing Cell-Based Therapies and Bioengineering Approach for Human Clinical Use
Workshop 1: ISCT-NAVRMA Joint Session – Veterinary Medicine in Developing Cell-Based Therapies and Bioengineering Approach for Human Clinical Use image
Daniel Weiss, MD, PhD (Chair)
University of Vermont, USA
Workshop 1: ISCT-NAVRMA Joint Session – Veterinary Medicine in Developing Cell-Based Therapies and Bioengineering Approach for Human Clinical Use image
Tracey Webb, DVM, PhD (Chair)
Colorado State University, USA
Andrew Hoffman, DVM, DVSc, DACVIM
University of Pennsylvania School of Veterinary Medicine, USA
Workshop 1: ISCT-NAVRMA Joint Session – Veterinary Medicine in Developing Cell-Based Therapies and Bioengineering Approach for Human Clinical Use image
Kyla Ortved, DVM, PhD
University of Pennsylvania School of Veterinary Medicine, USA
Dori Borjesson, BA, DVM, MPVM, PhD
UC Davis School of Veterinary Medicine, USA
10:45 - 12:15
Q&O Track 2: Managing Growth
Q&O Track 2: Managing Growth image
Lynn O’Donnell, PhD (Chair)
Ohio State University, James Cancer Hospital Columbus, USA
12:15 - 13:45
Lunch
12:30 - 13:30
Corporate Tutorial Hosted by Fresenius-Kabi
13:45 - 15:15
Plenary 2: iPS Pluripotent Stem Cells – True Replacement Cell Therapies
Plenary 2: iPS Pluripotent Stem Cells – True Replacement Cell Therapies image
Robert Deans, PhD (Chair)
BlueRock Therapeutics, USA
Plenary 2: iPS Pluripotent Stem Cells – True Replacement Cell Therapies image
Dan Kaufman, MD, PhD
University of California San Diego, USA
Stephanie Protze, PhD
University of Toronto, Canada
Plenary 2: iPS Pluripotent Stem Cells – True Replacement Cell Therapies image
Robert Deans, PhD
15:15 - 15:30
Coffee Break
15:30 - 17:00
Q&O Track 3: Stability
Karl Stasko, BSc, MPH (Chair)
Dana Farber Cancer Institute, USA
15:30 - 17:00
Workshop 2: ISCT Presidential Task Force – Regulatory Aspects of Unproven Cell and Gene Therapies in North America
Workshop 2: ISCT Presidential Task Force – Regulatory Aspects of Unproven Cell and Gene Therapies in North America image
Laertis Ikonomou, PhD (Chair)
Boston University, USA
Workshop 2: ISCT Presidential Task Force – Regulatory Aspects of Unproven Cell and Gene Therapies in North America image
Peter Marks, MD, PhD
Center for Biologics Evaluation and Research, FDA, USA
Lynne Boxer, DVM
Center for Veterinary Medicine, FDA, USA
Ajay Kuriyan, MD, MS
Department of Ophthalmology, University of Rochester Medical Center, USA
Workshop 2: ISCT Presidential Task Force – Regulatory Aspects of Unproven Cell and Gene Therapies in North America image
Kristin Matthews, PhD
Rice University's Baker Institute for Public Policy, USA
15:30 - 17:00
Workshop 3: Gene Replacement Therapy Using Adult Stem Cells
Workshop 3: Gene Replacement Therapy Using Adult Stem Cells image
Mitch Cairo, MD (Chair)
New York Medical College, USA
Workshop 3: Gene Replacement Therapy Using Adult Stem Cells image
Mitch Cairo, MD
New York Medical College, USA
Jeffrey Medin, PhD
Medical College of Wisconsin, USA
Paul Orchard, MD
University of Minnesota, USA
17:00 - 18:00
Corporate Symposium
18:00 - 18:30
Welcome Address
18:30 - 20:30
Welcome & Networking Reception
07:00 - 17:00
Registration
07:30 - 08:30
Q&O Track 4: Current Clinical Development Regulatory Guidance – Context and Implications
Q&O Track 4: Current Clinical Development Regulatory Guidance – Context and Implications image
Kurt Gunter, MD (Chair)
Cell Medica Inc., USA
Q&O Track 4: Current Clinical Development Regulatory Guidance – Context and Implications image
Peiman Hematti, MD
University of Wisconsin-Madison School of Medicine and Public Health, USA
Cynthia Molina
Triumvira, USA
07:30 - 08:30
Morning Session 2: Technologist Event
Morning Session 2: Technologist Event image
Lizette Caballero, BS, MLS(ASCP)CM (Chair)
UCSF Blood and Marrow Transplant Lab, USA
07:30 - 08:30
Morning Session 3: CAR-T Meet the Experts
Morning Session 3: CAR-T Meet the Experts image
Sarah Nikiforow, MD, PhD (Chair)
Dana-Farber Cancer Institute, USA
08:45 - 10:15
Plenary 3: Redirecting Immune Cells – T and NK cells aside from canonical CARs
Plenary 3: Redirecting Immune Cells – T and NK cells aside from canonical CARs image
Sarah Nikiforow, MD, PhD (Chair)
Dana-Farber Cancer Institute, USA
Plenary 3: Redirecting Immune Cells – T and NK cells aside from canonical CARs image
Denis-Claude Roy, MD, FRCPC
Hopital Maisonneuve-Rosemont, Canada
Plenary 3: Redirecting Immune Cells – T and NK cells aside from canonical CARs image
Lisa Butterfield, PhD
University of Pittsburgh Department of Medicine, USA
Sumithira Vasu, MBBS
Comprehensive Cancer Center, Ohio State University, USA
10:15 - 10:45
Coffee Break
10:45 - 12:15
Oral Abstracts Session 2
10:45 - 12:15
Advanced Practice Professionals* (APP) Track Session 1: Management of CRS toxicity or other reactions related to CAR therapy
Valkal Bhatt, PharmD, BCOP, BCPS (Chair)
Memorial Sloan Kettering Cancer Center, USA
Christina Bachmeier, PharmD, BCOP
Moffitt Cancer Center, USA
Marian Dam, DNP, APRN
Moffitt Cancer Center, USA
10:45 - 12:15
Workshop 4: Optimizing Clinical Trials in Cellular Therapy
Workshop 4: Optimizing Clinical Trials in Cellular Therapy image
Denis-Claude Roy, MD, FRCPC (Chair)
Hopital Maisonneuve-Rosemont, Canada
Lauralyn McIntyre, MD, MHSc, FRCPC
Ottawa Hospital Research Institute, Canada
Workshop 4: Optimizing Clinical Trials in Cellular Therapy image
Sarah Nikiforow, MD, PhD
Dana-Farber Cancer Institute, USA
Steven Devine, MD
CIBMTR, USA
12:15 - 13:45
Lunch
12:30 - 13:30
Corporate Tutorial Hosted by Fresenius-Kabi
13:45 - 15:15
Workshop 5: Engineering to Control Cell Environment during Expansion
Workshop 5: Engineering to Control Cell Environment during Expansion image
Erika Trauzzi (Chair)
Berkeley Lights Inc., USA
James Lim, PhD
Xcell Biosciences Inc., USA
Peter Beemiller
Berkeley Lights Inc., USA
Angelo Cardoso, MD, PhD
City of Hope, USA
13:45 - 15:15
Advanced Practice Professionals* (APP) Track Session 2: Responsibilities of the Investigator and the Lab in the investigation, communication and reporting of Adverse Events
Valkal Bhatt, PharmD, BCOP, BCPS (Chair)
Memorial Sloan Kettering Cancer Center, USA
Julia Thebiay
IMPACT, Mayo Clinic Rochester, USA
Ashwani Khurana, PhD
Mayo Clinic Rochester, USA
13:45 - 15:15
Q&O Track 5: ISCT-ASFA Joint Session – Current Concepts in Cell Collections: HPCs, CAR-T & Regulatory Oversight
Joseph Schwartz, MD, PhD (Co-Chair)
Columbia University, USA
Q&O Track 5: ISCT-ASFA Joint Session – Current Concepts in Cell Collections: HPCs, CAR-T & Regulatory Oversight image
Lizette Caballero, BS, MLS(ASCP)CM (Co-Chair)
UCSF Blood and Marrow Transplant Lab, USA
Q&O Track 5: ISCT-ASFA Joint Session – Current Concepts in Cell Collections: HPCs, CAR-T & Regulatory Oversight image
Donald Siegel, PhD, MD
Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, USA
Anand Padmanabhan, MD, PhD
Blood Center of Wisconsin, USA
Joseph Schwartz, MD, PhD
Columbia University, USA
15:15 - 15:45
Coffee Break
15:45 - 17:15
Workshop 6: CAR-T Racing: Amateurs & Rookies Looking to Contribute
Workshop 6: CAR-T Racing: Amateurs & Rookies Looking to Contribute image
Patrick Hanley, PhD (Chair)
Children’s National Health System, USA
Workshop 6: CAR-T Racing: Amateurs & Rookies Looking to Contribute image
Lizette Caballero, BS, MLS(ASCP)CM
UCSF Blood and Marrow Transplant Lab, USA
Workshop 6: CAR-T Racing: Amateurs & Rookies Looking to Contribute image
Paul Eldridge, PhD
UNC Lineberger Comprehensive Cancer Center, USA
Hema Dave, MD, MPH
Children’s National Medical Center, USA
15:45 - 17:15
Workshop 7: FDA & Other Government Agencies
Workshop 7: FDA & Other Government Agencies image
Olive Sturtevant, MSc (Chair)
Dana Farber Cancer Institute, USA
15:45 - 17:15
Q&O Track 6: Strategies for instituting materials management program for cell and gene therapy products
Aisha Khan, MS, MBA (Chair)
University of Miami, USA
17:15 - 18:15
Poster Session
07:00 - 12:00
Registration
07:30 - 08:30
Q&O Track 7: Synchronizing CMC preparation for commercial approval with regulatory accelerators
Yong Fan, MD (Chair)
A2Z Reg Solutions, USA
Mo Heidaran, PhD
PAREXEL, USA
07:30 - 08:30
Morning Session 4: Virus-Specific T Cells Meet the Experts
Catherine Bollard, MBChB, MD
Children's National Medical Center, USA
Michael Grimley, MD
Cincinnati Children's Hospital Medical Center, USA
John Barrett, MD
George Washington University Hospital, USA
08:45 - 10:15
Plenary Session 4: Emerging Engineering Strategies in Regenerative Medicine
Plenary Session 4: Emerging Engineering Strategies in Regenerative Medicine image
William Murphy, PhD (Chair)
University of Wisconsin Madison, USA
Plenary Session 4: Emerging Engineering Strategies in Regenerative Medicine image
Stephen Badylak, DVM, PhD, MD
Institute for Regenerative Medicine (MIRM), University of Pittsburgh, USA
Timothy Kamp, MD, PhD
Stem Cell and Regenerative Medicine Center, UW-Madison, USA
Plenary Session 4: Emerging Engineering Strategies in Regenerative Medicine image
Mervin Yoder, MA, MD
Indiana University School of Medicine, USA
10:15 - 10:45
Coffee Break
10:45 - 12:15
Q&O Track 8: Real World Evidence
Jiwen Zheng, PhD (Chair)
Tmunity Therapeutics, USA
10:45 - 12:15
Oral Abstracts Session 3
10:45 - 12:15
Workshop 8: CAR-T Racing: The Pro Circuit + Future Prospects
Workshop 8: CAR-T Racing: The Pro Circuit + Future Prospects image
Bruce Levine, PhD (Chair)
University of Pennsylvania, USA
Workshop 8: CAR-T Racing: The Pro Circuit + Future Prospects image
Rebecca Gardner, MD
Seattle Children’s Hospital, USA
Krishanu Saha, PhD
University of Wisconsin-Madison, USA
Workshop 8: CAR-T Racing: The Pro Circuit + Future Prospects image
Saar Gill, MD, PhD
Perelman School of Medicine, University of Pennsylvania, USA
Select date to see events.